|Articles|December 22, 2009
SCDM Certification Program Reaches 500 CCDMs Worldwide
Advertisement
MILWAUKEE – The Society for Clinical Data Management announced that is has recently certified its 500th Certified Clinical Data Manager (CCDM).
The CCDM credential is an elite mark of excellence in and commitment to clinical data management. Approximately 160 CCDMs were certified in 2009, nearly 40% of whom live outside North America.
“The CCDM designation is recognized globally as a standard for quality data management staff,” said 2010 SCDM Chair Ralph J. Russo, CCDM. “It provides the clinical research industry with a measure of expertise.”
Since its inception in 2005, the Certified Clinical Data Manager program has enhanced the quality and professionalism of CDMs worldwide. To earn the CCDM credential, candidates must first meet minimum standards of education and experience, then pass a challenging exam testing knowledge of best practices in all areas of clinical data management. Once obtained, certification must be renewed every three years by completing education activities or retaking the exam.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
2
Latest NIMBLE Study Results Highlight Progress in gMG Research
3
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
4
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
5